The possible involvement of this cytokine in the pathogenesis of MS was reinforced by the observations that IL-18 production by PBMCs of MS patients is increased (14) and that IL-18 is expressed by oligodendrocytes in brain tissues from patients with active MS (37). This evidence concerns the gene IL18 and myeloid sarcoma.